| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950299A1 Mammalian receptor proteins; related reagents and methods |
| 07/30/2008 | EP1950297A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 07/30/2008 | EP1950226A2 Receptors for human interleukin-12 |
| 07/30/2008 | EP1950222A1 Method for proving antibodies in body fluids via an immune reaction with glycoprotein 2 (GP2) from zymogen granula of the pancreas for a differential diagnosis of inflammable intestinal illnesses and chronic pancreatitis |
| 07/30/2008 | EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis |
| 07/30/2008 | EP1949915A2 Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949913A1 Immunostimulatory combination for the prophylactics and treatment of hepatitis c |
| 07/30/2008 | EP1949912A2 Treatment of chronic lymphcytic leukemia (CLL) using chimeric anti-CD20 antibody |
| 07/30/2008 | EP1949911A2 Treatment of chronique lymphocytic leukemia using chimeric anti-CD20 antibody. |
| 07/30/2008 | EP1949910A1 Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody. |
| 07/30/2008 | EP1949902A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 07/30/2008 | EP1949103A2 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 07/30/2008 | EP1948818A2 Use of b cell expansion agents in generating antibodies |
| 07/30/2008 | EP1948802A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 07/30/2008 | EP1948798A1 Anti-alpha2 integrin antibodies and their uses |
| 07/30/2008 | EP1948783A1 Novel bacterium and vaccine |
| 07/30/2008 | EP1948782A2 Vaccine adjuvants |
| 07/30/2008 | EP1948695A2 Immunogenic compositions and methods of use |
| 07/30/2008 | EP1948693A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 07/30/2008 | EP1948692A2 Rankl antibody-pth/pthrp chimeric molecules |
| 07/30/2008 | EP1948691A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH a4ß7INTEGRIN |
| 07/30/2008 | EP1948680A2 Methods and compounds for lymphoma cell detection and isolation |
| 07/30/2008 | EP1948234A2 Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions |
| 07/30/2008 | EP1948233A2 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 07/30/2008 | EP1948232A2 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 07/30/2008 | EP1948231A1 Composition comprising a colloidal synthetic bioresorbable vector and a viral vector |
| 07/30/2008 | EP1948230A2 Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| 07/30/2008 | EP1948229A2 Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 07/30/2008 | EP1948228A2 A lentiviral vector-based vaccine |
| 07/30/2008 | EP1948227A2 Influenza combinatorial antigen vaccine |
| 07/30/2008 | EP1948226A1 A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif |
| 07/30/2008 | EP1948225A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 07/30/2008 | EP1948220A2 Methods of decreasing vascular calcification using il-1 inhibitors |
| 07/30/2008 | EP1948214A2 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| 07/30/2008 | EP1549673B1 Novel mhc ii associated peptides |
| 07/30/2008 | EP1494752B1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 07/30/2008 | EP1478394B1 Stabilized TNFR-Fc composition comprising arginine |
| 07/30/2008 | EP1423525B1 Recombinant mva capable of expressing structural hcv antigens |
| 07/30/2008 | EP1340086B1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| 07/30/2008 | EP1239876B1 Hcv vaccine compositions |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP0912738B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 07/30/2008 | EP0776209B1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 07/30/2008 | EP0659276B2 Immunoassay for detecting collagen or collagen fragments |
| 07/30/2008 | CN101233155A 人抗表皮生长因子受体抗体 Human anti-epidermal growth factor receptor antibody |
| 07/30/2008 | CN101233154A Stable and soluble antibodies inhibiting TNF alpha |
| 07/30/2008 | CN101232901A Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 07/30/2008 | CN101230340A 纤维蛋白溶解活性多肽 Fibrinolytic activity of the polypeptide |
| 07/30/2008 | CN101230336A Gm-negative ehv-mutants |
| 07/30/2008 | CN101230335A Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 07/30/2008 | CN101230334A Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 07/30/2008 | CN101230104A Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 07/30/2008 | CN101230103A Human recombinant anti-IgE antibody |
| 07/30/2008 | CN101230102A Neutralizing antibodies against GDF-8 and uses therefor |
| 07/30/2008 | CN101230100A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/30/2008 | CN101230099A Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/30/2008 | CN101230098A Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/30/2008 | CN101230096A Peptide derived from hepatitis C virus |
| 07/30/2008 | CN101229381A Acute promyelocytic leukemia DNA vaccine, preparing method thereof and applications |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229370A Autologous T-cell vaccines against multiple sclerosis |
| 07/30/2008 | CN100406562C Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 07/30/2008 | CN100406554C Colibacillus containing human source guide suppository dissolving antibody gene and its secretion producg |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406062C Preparation process of autogenous high-immunity serum for treating post-weaning multi systemic wasting syndrome of baby pig |
| 07/30/2008 | CN100406061C Use of regulating T-cell loss agent in preparing medicament |
| 07/30/2008 | CN100406060C Adjuvant composition |
| 07/30/2008 | CN100406004C Vaccine composition and method of using same |
| 07/30/2008 | CA2627364A1 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 07/29/2008 | US7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 07/29/2008 | US7405290 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 07/29/2008 | US7405288 V-like domain binding molecules and polynucleotides encoding therefor |
| 07/29/2008 | US7405276 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 07/29/2008 | US7405275 Nucleic acid and vectors encodes antibodies ; antigen binding fragments |
| 07/29/2008 | US7405273 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 07/29/2008 | US7405268 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/29/2008 | US7405077 Sperm protein 17 for the diagnosis and treatment of cancer |
| 07/29/2008 | US7405075 Detecting binding between serum and peptide; immunogenic; vaccines |
| 07/29/2008 | US7405061 for drug screening/diagnosis and/or treatment of a variety of human diseases and cancers; immunotherapy; genetic engineering |
| 07/29/2008 | US7405060 Gene amplification methods |
| 07/29/2008 | US7405048 Improving production by immunocompetent cells; side effect reduction |
| 07/29/2008 | US7405039 Hepatitis B virus (HBV) variant with reduced sensitivity to entecavir (ETV) and/or lamivudine (LMV) for use as tool in screening viricidal agents and therapeutic protocols which prevent infection, replication and/or release of viral particles |
| 07/29/2008 | US7404963 Flagellin-based adjuvants and vaccines |
| 07/29/2008 | US7404962 Combination kit used in the treatment of malaria |
| 07/29/2008 | US7404961 Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins |
| 07/29/2008 | US7404960 Multivalent vaccine composition having increased stability of capsular polysaccharide |
| 07/29/2008 | US7404958 Administering polypeptide which elicits an immune response |
| 07/29/2008 | US7404956 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/29/2008 | US7404955 Methods of inhibiting or neutralizing TNFα in patients with tissue injury |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404953 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | US7404950 Induced activation in dendritic cell |
| 07/29/2008 | US7404270 Tumor antigen |
| 07/29/2008 | CA2254914C Methods of terminal sterilization of biological products |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2247117C Immunogenic complex, iscom, for use in preparing a vaccine for juvenile individuals |